Screener
Ironwood Pharmaceuticals IRWD Net debt / EBITDA
Net debt / EBITDA at other companies
Other financials
Where this comes from
Calculated from Ironwood Pharmaceuticals’s reported figures.
Based on the most recent quarter.
The source filing: Ironwood Pharmaceuticals’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:07 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-091987
FAQ
- What is Ironwood Pharmaceuticals's net debt / EBITDA?
- Ironwood Pharmaceuticals (IRWD) reported net debt / EBITDA of -0.3× in Q2 2026.
- How has Ironwood Pharmaceuticals's net debt / EBITDA changed year-over-year?
- Ironwood Pharmaceuticals's net debt / EBITDA decreased by 117.7% year-over-year, from 1.6× to -0.3×.
- What is the long-term trend for Ironwood Pharmaceuticals's net debt / EBITDA?
- Over 4 years (2020 to 2025), Ironwood Pharmaceuticals's net debt / EBITDA has grown at a -67.3% compound annual growth rate (CAGR), from -2.3× to -0×.
- What does net debt / EBITDA mean?
- Net debt (total debt minus cash) divided by trailing-twelve-month EBITDA. Expresses leverage in years — roughly how long it would take to repay net debt out of operating cash earnings.
Ask your AI about Ironwood Pharmaceuticals's net debt / ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude